Drug Profile
Research programme: leukotriene A4 hydrolase inhibitors - deCODE genetics
Alternative Names: LTA4H inhibitors - deCODELatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator deCODE genetics
- Class Ethers; Piperidines; Pyrrolidines
- Mechanism of Action Leukotriene A4 hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Myocardial infarction; Stroke
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Myocardial-infarction in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Stroke in USA
- 17 Apr 2007 Preclinical trials in Stroke in USA (unspecified route)